Abstract:Background: The ε2, ε3 and ε4 alleles of apolipoprotein (APO) E gene constitute a common polymorphism in most populations, among which the APOEε4 allele is known to increase both the susceptibility and severity of Alzheimer's Disease (AD), and it is also associated with lipid profiles. High serum total cholesterol (TC) level in middle age has been proven to be a risk factor for AD and its related pathology. In addition, sex may alter the risk associated with the APOEε4 allele, and gender-specific APOE gene interactions can alter the response to anticholinesterase therapy. Therefore, sex is an important factor in studying the relationship between the APOE gene, lipid profiles and AD, and the underlying mechanism. However, there are few studies on whether there are differences in the effects of APOEε2 and APOEε4 on AD patients and healthy people of different genders, respectively.Material and methods: A total of 549 participants, including 298 AD patients and 251 body mass index (BMI)-matched health controls (HCs), were enrolled. Lipid profiles and APOE genes in both AD patients and matched controls were determined. The cognitive functions of the AD patients were evaluated using the Mini-mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).Results: (1) The levels of TC and LDL in the AD group were higher than those in HCs. Subgroup analysis found that the AD patients with the APOEε4 allele had higher levels of TC and LDL than HCs carrying the APOEε4 allele, while in individuals without the APOEε4 allele. There was no significant difference in TG and HDL levels between the AD group and HCs. (2) The levels of TC and LDL in the APOEε4 carriers were higher than those in non-APOEε4 carriers. Subgroup analysis found that the increase of TC and LDL in the APOEε4 carriers was found in the AD and female populations, but not in HCs and male populations. (3) The levels of TC and LDL in the APOEε2 carriers were lower than those in non-APOEε2 carriers. Subgroup analysis found that the TC of APOEε2 carriers was lower than that of non-carriers in the male AD population, but not in the female AD population, female HCs, and male HCs. (4) The levels of TC, HDL and LDL in the female population were higher than the male population. (5) The increased LDL level may increase the risk of AD in female people carrying APOEε4.Conclusion: AD patients had higher TC and LDL levels than HCs, especially in the population with the APOEε4 allele. The levels of TC and LDL in the APOEε4 carriers were higher than those in non-APOEε4 carriers, especially in the female AD populations. The TC of APOEε2 carriers was lower than that of non-carriers, especially in male AD populations.

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome

Impact of sex and APOE-ε4 genotype on patterns of regional brain atrophy in Alzheimer's disease and healthy aging

Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer’s disease: A 31Phosphorus MR spectroscopy study

APOE Genotype-specific Methylation Patterns are Linked to Alzheimer Disease Pathology and Estrogen Response

Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer’s Disease Across Distinct Brain Regions

Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease

Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

APOE4 and Chronic Health Risk Factors are Associated with Sex-Specific Preclinical Alzheimers Disease Neuroimaging Biomarkers

Sex-Specific Metabolic Pathways Were Associated with Alzheimer’s Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort

Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort

Multiomics integrative analysis identifies APOE allele-specific blood biomarkers associated to Alzheimer’s disease etiopathogenesis

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum

Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults

Apolipoprotein E and sex modulate fatty acid metabolism in a prospective observational study of cognitive decline

APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer's disease

Effects of Apolipoprotein E Gene and Sex On Serum Lipid Profiles in Alzheimer's Disease

Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers

APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains

Metabolomics profiling reveals distinct, sex‐specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease